KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for Hims & Hers Health (HIMS) over the last 7 years, with Q3 2025 value amounting to $629.7 million.

  • Hims & Hers Health's Cash & Current Investments rose 14786.14% to $629.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $629.7 million, marking a year-over-year increase of 14786.14%. This contributed to the annual value of $300.3 million for FY2024, which is 3587.19% up from last year.
  • Hims & Hers Health's Cash & Current Investments amounted to $629.7 million in Q3 2025, which was up 14786.14% from $1.1 billion recorded in Q2 2025.
  • Hims & Hers Health's Cash & Current Investments' 5-year high stood at $1.1 billion during Q2 2025, with a 5-year trough of $179.6 million in Q4 2022.
  • Its 5-year average for Cash & Current Investments is $305.8 million, with a median of $227.3 million in 2024.
  • In the last 5 years, Hims & Hers Health's Cash & Current Investments soared by 2280261.07% in 2021 and then plummeted by 3855.57% in 2022.
  • Over the past 5 years, Hims & Hers Health's Cash & Current Investments (Quarter) stood at $247.3 million in 2021, then decreased by 27.36% to $179.6 million in 2022, then grew by 23.02% to $221.0 million in 2023, then soared by 35.87% to $300.3 million in 2024, then soared by 109.74% to $629.7 million in 2025.
  • Its last three reported values are $629.7 million in Q3 2025, $1.1 billion for Q2 2025, and $322.7 million during Q1 2025.